Matthias Manne Knopp

Dr. Matthias Manne Knopp

Department of Pharmacy, Bioneer A/S, 2100 Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MRMalte Bille Rask
Malte Bille Rask
MKMatthias Manne Knopp
Matthias Manne Knopp
NONiels Erik Olesen
Niels Erik Olesen
RHRené Holm
René Holm
TRThomas Rades
Thomas Rades

1 December 2019 in International Journal of Pharmaceutics: X
Verified
Journal Article
Open access
CBChristoffer G. Bavnhøj
Christoffer G. Bavnhøj
MKMatthias Manne Knopp
Matthias Manne Knopp
CMCecilie M. Madsen
Cecilie M. Madsen
Korbinian LöbmannKorbinian Löbmann
Korbinian Löbmann
In this study, the influence of the mesoporous silica (MS) textural properties (surface area, pore diameter, and pore volume) on drug loading capacity (monomolecular loading capacity and pore filling capacity) was investigated theoretically and experimentally using a thermoanalytical method. The loading capacities of three model drugs (celecoxib, cinnarizine, and paracetamol) were determined in five different MS grades of Sylysia® with identical chemical composition, but varying surface area, pore diameter and pore volume. The experimentally determined loading capacities were compared to theoretical loading capacities, calculated based on the surface area and amorphous density of the drugs, and the surface area and pore volume of the MS. The findings of the study showed that the monomolecular loading capacity generally increased with increasing surface area and decreasing pore volume of the MS. However, the MS grade with the highest surface area did not display the highest monomolecular loading capacity for any of the three drugs. This was probably a result of the decreasing pore diameter necessary to accommodate the increasing surface area of the MS i.e., if the pore is smaller than the drug molecule, the drug cannot access the available surface area. For these systems, the amorphous density of the drug and the pore volume of the MS was used to estimate the theoretical pore filling capacity, which was in good agreement with the experimentally determined loading capacity. In conclusion, this study showed that both the pore volume and surface area of the MS will have an influence on the drug loading capacity and that this can be estimated with good accuracy both theoretically and experimentally.

30 May 2018 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
MEMagnus Edinger
Magnus Edinger
MKMatthias Manne Knopp
Matthias Manne Knopp
HKHugo Kerdoncuff
Hugo Kerdoncuff
JRJukka Rantanen
Jukka Rantanen
TRThomas Rades
Thomas Rades
Korbinian LöbmannKorbinian Löbmann
Korbinian Löbmann

1 June 2018 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
NHNele-Johanna Hempel
Nele-Johanna Hempel
KBKatharina Brede
Katharina Brede
NONiels Erik Olesen
Niels Erik Olesen
NGNatalja Genina
Natalja Genina
MKMatthias Manne Knopp
Matthias Manne Knopp
Korbinian LöbmannKorbinian Löbmann
Korbinian Löbmann

27 May 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CACamilla Asgreen
Camilla Asgreen
MKMatthias Manne Knopp
Matthias Manne Knopp
JSJeppe Skytte
Jeppe Skytte
Korbinian LöbmannKorbinian Löbmann
Korbinian Löbmann
In this study, the putative correlation between the molecular mobility of a polymer and the ball milling drug amorphization kinetics (i.e., time to reach full drug amorphization, ta) was studied using different grades of dextran (Dex) and polyvinylpyrrolidone (PVP) and the two model drugs indomethacin (IND) and chloramphenicol (CAP). In general, IND had lower ta values than CAP, indicating that IND amorphized faster than CAP in the presence of the polymers. In addition, an increase in polymer molecular weight (Mw) also led to an increase in ta for all systems investigated up to a critical Mw for each polymer, which was in line with an increase of the glass transition temperature (Tg) up to the critical Mw of each polymer. Hence, the increase in ta seemed to correlate well with the Tg/Mw of the polymers, which indicates that the polymers’ molecular mobility had an influence on the drug amorphization kinetics during ball milling.

24 January 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CHChristoffer Gerner Bavnhøj Hansen
Christoffer Gerner Bavnhøj Hansen
MKMatthias Manne Knopp
Matthias Manne Knopp
Korbinian LöbmannKorbinian Löbmann
Korbinian Löbmann
The encapsulation of drugs within mesoporous silica (MS) has for several years been a subject of research. Previous studies proposed that drug loadings up to the monomolecular loading capacity (MLC) are the optimal choice for maintaining the drug in an amorphous form, whereas filling the pores above the monolayer and up to the pore filling capacity (PFC) may introduce some physical instabilities. The aim of this study was to assess the effect of drug loading in MS-based amorphous formulations on the stability of the amorphous form of the drug as well as the dissolution. In particular, the following drug loadings were investigated: below MLC, at MLC, between MLC and PFC and at PFC. The drug-loaded MS formulations were analyzed directly after preparation and after 18 months of storage under accelerated conditions (40 °C in both dry and humid conditions). The MLC and PFC for the drug celecoxib (CEL) on the MS ParteckSLC500 (SLC) were determined at 33.5 wt.% and 48.4 wt.%, respectively. This study found that SLC can effectively preserve the amorphous form of the drug for 18 months, provided that the loading is below the PFC (<48.4 wt.%) and no humidity is present. On the other hand, drug loading at the PFC showed recrystallization even when stored under dry conditions. Under humid conditions, however, all samples, regardless of drug loading, showed recrystallization upon storage. In terms of dissolution, all freshly prepared formulations showed supersaturation. For drug loadings below PFC, a degree of supersaturation (DS) around 15 was measured before precipitation was observed. For drug loadings at PFC, the DS was found to be lower and only 6-times compared to the crystalline solubility. Lastly, for those samples that remained amorphous during storage for 18 months, the release profiles were found to be the same as the freshly loaded samples, with similar Cmax, Tmax and dissolution rate.